Earlier research has shown that birth notifications in Kuwait often have a high amount of missing data on many items such as weeks of gestation and complications of pregnancy. The situation has deteriorated even further since the Iraqi occupation. To rectify this situation in the Maternity Hospital, an evaluative management study was conducted. After collecting benchmark data for December 1992, certain administrative interventions to improve data completeness were made during January–March 1993. Data for April 1993 showed that only marginal improvements had occurred. Additional interventions were implemented during January–March 1994. Substantial improvements were realized as indicated by the decrease in the amount of missing data. For example, the percentage of missing data on weeks of gestation decreased from 91% in 1993 to 18% in 1994. However, it was found that while the required information was filled out on the labor room form, it was not transferred to the notification, as required. In light of the preceding findings, further efforts at improvement are currently under way.

Keywords:
Birth notification, Data quality, Birth registration, Kuwait
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.